Project 2025 would revoke approval from the U.S. Food and Drug Administration (FDA), criminalize mailing medication abortion, or even enlist the U.S. Environmental Protection Agency (EPA) as part of their anti-abortion efforts.
Over two decades of medical practice show that mifepristone — medication abortion — is safe and effective. In fact, just last year, nearly two-thirds of all pregnant people relied on medication abortion for their abortion care. This is one of the last lifelines for millions of pregnant people across the United States, as many state governments are ramping up attacks. The anti-abortion extremists behind Project 2025, not content with merely overturning Roe v. Wade, want to attack access to medication abortion nationwide by any means necessary.
{A} Project 2025 would weaponize the long-dormant Comstock Act to try and make the delivery of medication abortion by mail illegal. Originally passed in the 19th century to restrict the types of things that could be mailed, the Comstock Act is, today, in District Court Judge Robert Chambers’ own words: a “widely abrogated 19th century statute.” Despite the DOJ, the courts, and Congress already making clear that the Comstock Act does not apply to legal abortion care, Project 2025 plans to weaponize the DOJ and resurrect this Act to ban nationwide medication abortion access.
{B} Project 2025 would have the FDA reverse approval of this safe and effective medication. Reversing federal approval of medication abortion could deprive people of essential health care, even in states where abortion remains legal. In states where abortion is banned or restricted, this would further subject people to the whims of state legislatures, many of which have actively pushed or enacted abortion restrictions since the Supreme Court overturned Roe v. Wade.
paragraph 2 or leave blank
for {C} IN THEIR OWN WORDS: “A bare-minimum policy of limiting abortion pills to the pre-2016 policy of 49 days gestation, returning to the pre-2021 in- person dispensing requirement, and returning to requiring prescribers to report all serious adverse events, not just deaths, to the drug sponsor would increase women’s health and safety.:” DIRECT FROM “Mandate for Leadership” p.459 and for {A} see p 562 for {B} see p 458